Fidelity Advisor Biotechnology Fund - Class I (FBTIX)
NASDAQ · Mutual Fund
· Delayed Price · Currency is USD
29.56
+0.13 (0.44%)
Jul 3, 2025, 4:00 PM EDT
FBTIX Holdings List
As of May 31, 2025
No. | Symbol | Name | % Weight |
---|---|---|---|
1 | ABBV | AbbVie Inc. | 19.38% |
2 | GILD | Gilead Sciences, Inc. | 8.75% |
3 | ALNY | Alnylam Pharmaceuticals, Inc. | 7.26% |
4 | ASND | Ascendis Pharma A/S | 5.53% |
5 | AMGN | Amgen Inc. | 5.25% |
6 | ARGX | argenx SE | 4.92% |
7 | NBIX | Neurocrine Biosciences, Inc. | 2.63% |
8 | NUVL | Nuvalent, Inc. | 2.38% |
9 | PCVX | Vaxcyte, Inc. | 1.99% |
10 | VRDN | Viridian Therapeutics, Inc. | 1.90% |
11 | MRUS | Merus N.V. | 1.80% |
12 | SLNO | Soleno Therapeutics, Inc. | 1.75% |
13 | REGN | Regeneron Pharmaceuticals, Inc. | 1.62% |
14 | XENE | Xenon Pharmaceuticals Inc. | 1.60% |
15 | APGE | Apogee Therapeutics, Inc. | 1.35% |
16 | SRRK | Scholar Rock Holding Corporation | 1.31% |
17 | CRNX | Crinetics Pharmaceuticals, Inc. | 1.30% |
18 | VKTX | Viking Therapeutics, Inc. | 1.27% |
19 | EXAS | Exact Sciences Corporation | 1.26% |
20 | AKRO | Akero Therapeutics, Inc. | 1.08% |
21 | EBR: UCB | UCB SA | 0.95% |
22 | RYTM | Rhythm Pharmaceuticals, Inc. | 0.90% |
23 | RZLT | Rezolute, Inc. | 0.88% |
24 | ELVN | Enliven Therapeutics, Inc. | 0.84% |
25 | ACLX | Arcellx, Inc. | 0.78% |
26 | SYRE | Spyre Therapeutics, Inc. | 0.78% |
27 | CLDX | Celldex Therapeutics, Inc. | 0.72% |
28 | CGON | CG Oncology, Inc. | 0.72% |
29 | CYTK | Cytokinetics, Incorporated | 0.72% |
30 | CTMX | CytomX Therapeutics, Inc. | 0.71% |
31 | ZBIO | Zenas BioPharma, Inc. | 0.70% |
32 | IMVT | Immunovant, Inc. | 0.70% |
33 | INSM | Insmed Incorporated | 0.64% |
34 | GPCR | Structure Therapeutics Inc. | 0.61% |
35 | ORKA | Oruka Therapeutics, Inc. | 0.61% |
36 | IRON | Disc Medicine, Inc. | 0.61% |
37 | DNTH | Dianthus Therapeutics, Inc. | 0.60% |
38 | NAMS | NewAmsterdam Pharma Company N.V. | 0.60% |
39 | JANX | Janux Therapeutics, Inc. | 0.60% |
40 | COGT | Cogent Biosciences, Inc. | 0.57% |
41 | SMMT | Summit Therapeutics Inc. | 0.55% |
42 | NRIX | Nurix Therapeutics, Inc. | 0.54% |
43 | STOK | Stoke Therapeutics, Inc. | 0.53% |
44 | KYMR | Kymera Therapeutics, Inc. | 0.52% |
45 | UPB | Upstream Bio, Inc. | 0.51% |
46 | n/a | Fidelity Cash Central Fund | 0.50% |
47 | JBIO | Jade Biosciences, Inc. | 0.49% |
48 | TVTX | Travere Therapeutics, Inc. | 0.42% |
49 | DNLI | Denali Therapeutics Inc. | 0.41% |
50 | TECX | Tectonic Therapeutic, Inc. | 0.41% |
As of May 31, 2025